Reporter Oct 2 2015
Rational design of novel antifungals
Oct. 7, 2015—Structural and molecular details of an anti-fungal target's interaction with inhibitors suggest ways to design better treatments for fungal infections.
Potential target for lung cancer therapy
Oct. 5, 2015—The glutamine transporter protein appears to contribute to the survival of lung cancer cells, suggesting it may be a useful diagnostic biomarker and target for therapies.
The yin and yang of COX-2
Oct. 2, 2015—New findings add to the understanding of how the enzyme COX-2 works, which is critical to the development of COX-2-targeted anti-inflammatory drugs.
Major grant to transform region’s clinical practices
Oct. 1, 2015—Vanderbilt University has received a contract from the Centers for Medicare and Medicaid Services (CMS) for up to $28 million over four years to help more than 4,000 clinicians in the Southeast transform their clinical practices in ways that improve quality of patient care and hold down costs.
Collaboration seeks to develop new therapies for bone, other diseases
Oct. 1, 2015—La Jolla Pharmaceutical Co. and Vanderbilt University have signed a research and license agreement covering Vanderbilt’s research program and intellectual property rights related to compounds that block bone morphogenetic protein (BMP) type-I receptors. The compounds have therapeutic potential in a broad range of diseases, including rare genetic disorders.
Donation to bring computers to thousands of MNPS families
Oct. 1, 2015—A few thousand families in the Metro Nashville Public Schools system will now have computers at home, thanks to Vanderbilt University Medical Center’s donation of 3,800 lightly used computers.
Tolerating a transplant
Oct. 1, 2015—A new genetic model has generated new strategies for promoting tolerance to transplants – and improving long-term transplant outcomes – in the background of autoimmune disease.
New online system for animal research protocols set to launch
Oct. 1, 2015—Animal Research Information Enterprise System (ARIES), a new online system for submitting animal research protocols, will be launched at Vanderbilt University on Oct. 12.
Infants born with NAS more likely to be readmitted: Study
Oct. 1, 2015—Infants diagnosed with drug withdrawal symptoms at birth, also known as neonatal abstinence syndrome (NAS), are nearly 2.5 times as likely to be readmitted to the hospital in the first month after being discharged compared with full-term infants born without complications, according to new Vanderbilt research released in the journal Hospital Pediatrics.
VUMC completes transition to new ICD-10 system
Oct. 1, 2015—After months transitioning clinics across Vanderbilt University Medical Center and training clinicians and staff, the move to the new medical coding and reporting system is complete.
VICC investigators land Komen breast cancer grants
Oct. 1, 2015—Two Vanderbilt-Ingram Cancer Center (VICC) investigators — Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of VICC, and Valerie Jansen, M.D., Ph.D., medical oncology fellow — have received new cancer research grants awarded by Susan G. Komen, the world’s largest nonprofit funder of breast cancer research.
Myers set as keynote speaker for Oct. 13 Levi Watkins Jr. Lecture
Oct. 1, 2015—Woodrow Myers Jr., M.D., chief executive officer of Corizon Health, will be the keynote speaker at the 14th annual Levi Watkins Jr. Lecture.
